Articles with "bcr" as a keyword



Optimization of peripheral blood volume for in silico reconstitution of the human B‐cell receptor repertoire

Sign Up to like & get
recommendations!
Published in 2022 at "FEBS Open Bio"

DOI: 10.1002/2211-5463.13467

Abstract: B cells recognize antigens via membrane‐expressed B‐cell receptors (BCR) and antibodies. Similar human BCR sequences are frequently found at a significantly higher frequency than that theoretically calculated. Patients infected with SARS‐CoV2 and HIV or with… read more here.

Keywords: frequency; silico reconstitution; repertoire; bcr ... See more keywords

Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer Medicine"

DOI: 10.1002/cam4.5212

Abstract: Asciminib, a first‐in‐class, allosteric inhibitor of BCR‐ABL1 that acts by STAMP (Specifically Targeting the ABL Myristoyl Pocket), is a novel therapeutic option for patients with chronic myeloid leukemia (CML). In the global, phase 3, open‐label… read more here.

Keywords: ascembl study; cml; subgroup analysis; study ... See more keywords
Photo by nci from unsplash

BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat?

Sign Up to like & get
recommendations!
Published in 2019 at "Cancer"

DOI: 10.1002/cncr.31848

Abstract: BCR/ABL1–like acute lymphoblastic leukemia (ALL) accounts for 15% to 30% of B‐lineage ALL, with a peak of incidence occurring in adolescence. This subgroup of patients is characterized by a peculiar transcriptional profile that resembles that… read more here.

Keywords: bcr; abl1 like; lymphoblastic leukemia; acute lymphoblastic ... See more keywords

Improving naive B cell isolation by absence of CD45RB glycosylation and CD27 expression in combination with BCR isotype

Sign Up to like & get
recommendations!
Published in 2022 at "European Journal of Immunology"

DOI: 10.1002/eji.202250013

Abstract: In past years ex vivo and in vivo experimental approaches involving human naive B cells have proven fundamental for elucidation of mechanisms promoting B cell differentiation in both health and disease. For such studies, it… read more here.

Keywords: cell; naive cell; cell isolation; naive cells ... See more keywords
Photo by nci from unsplash

Role and timing of new drugs in CLL

Sign Up to like & get
recommendations!
Published in 2017 at "Hematological Oncology"

DOI: 10.1002/hon.2397

Abstract: Signaling through the B‐cell receptor (BCR) has emerged as a potential key mechanism in CLL pathogenesis. It has been suggested that the BCR may induce antigen‐independent cell‐autonomous signaling in CLL. The importance of BCR signaling… read more here.

Keywords: role timing; timing new; cll; bcr ... See more keywords

Immune features revealed by single‐cell RNA and single‐cell TCR/BCR sequencing in patients with rheumatoid arthritis receiving COVID‐19 booster vaccination

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Medical Virology"

DOI: 10.1002/jmv.29573

Abstract: Coronavirus disease 2019 (COVID‐19), caused by SARS‐CoV‐2, have profoundly affected human health. Booster COVID‐19 vaccines have demonstrated significant efficacy in reducing infection and severe cases. However, the effects of booster COVID‐19 vaccines on key immune… read more here.

Keywords: single cell; booster vaccination; cell; bcr ... See more keywords
Photo from archive.org

Imaging the Interactions Between B Cells and Antigen-Presenting Cells.

Sign Up to like & get
recommendations!
Published in 2018 at "Methods in molecular biology"

DOI: 10.1007/978-1-4939-7474-0_10

Abstract: In vivo, B cells are often activated by antigens that are displayed on the surface of antigen-presenting cells (APCs). Binding of membrane-associated antigens to the B cell receptor (BCR) causes rapid cytoskeleton-dependent changes in the… read more here.

Keywords: imaging interactions; bcr; presenting cells; model antigens ... See more keywords

Synthesis and biological evaluation of phenyl-amino-pyrimidine and indole/oxindole conjugates as potential BCR-ABL inhibitors

Sign Up to like & get
recommendations!
Published in 2019 at "Medicinal Chemistry Research"

DOI: 10.1007/s00044-019-02318-4

Abstract: AbstractIndole/isatin conjugated phenyl-amino-pyrimidine derivatives have been synthesized, characterized and evaluated in vitro for their potential as BCR-ABL inhibitors. Among the series, all derivatives (7a–7o) were found to be more cytotoxic than standard Imatinib against K-562… read more here.

Keywords: bcr; abl inhibitors; amino pyrimidine; bcr abl ... See more keywords

Asciminib resistance of a new BCR::ABL1 p.I293_K294insSSLRD mutant detected in a Ph + ALL patient

Sign Up to like & get
recommendations!
Published in 2025 at "Annals of Hematology"

DOI: 10.1007/s00277-024-06142-8

Abstract: Chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia patients largely benefit from an expanding tyrosine kinase inhibitors (TKIs) toolbox that has improved the outcome of both diseases. However, TKI success is continuously challenged by… read more here.

Keywords: resistance; abl1 i293; bcr; mutation ... See more keywords

Inotuzumab therapy resulted in molecular remission of relapsed/resistant B-cell acute lymphoblastic leukemia with BCR::ABL1 Lys404Glu mutation

Sign Up to like & get
recommendations!
Published in 2025 at "Annals of Hematology"

DOI: 10.1007/s00277-025-06385-z

Abstract: The Philadelphia positive acute lymphoblastic leukemia (ALL BCR::ABL1 positive) is characterized by the presence of the t(9;22)(q34;q11) resulting in the formation of the BCR::ABL1 fusion, constant high cellular BCR-ABL1 tyrosine kinase activity, abnormal lymphoid cell… read more here.

Keywords: treatment; therapy; bcr; mutation ... See more keywords

Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale

Sign Up to like & get
recommendations!
Published in 2019 at "International Journal of Clinical Oncology"

DOI: 10.1007/s10147-019-01419-9

Abstract: BackgroundMajor BCR-ABL1 mRNA in patients with chronic myeloid leukemia (CML) has generally been analysed by real-time polymerase chain reaction (PCR). Application of the international scale (IS) for the quantification of major BCR-ABL1 mRNA has been… read more here.

Keywords: bcr; real time; pcr; abl1 mrna ... See more keywords